Trial intelligence / Profile preview

Comparison of postoperative analgesia with two different doses of intrathecal nalbuphine

TCTR20250507004Phase 4Completed

Sponsor
N/A
Start
Feb 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nalbuphine in postoperative pain, sponsored by N/A. Started Feb 2024; status: completed.

02

Drugs

nalbuphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on TCTR20250507004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250507004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call